Last edition
News about
USFDA Approves Alembic Pharmaceuticals' Sumatriptan Single-Dose Autoinjector
Alembic Pharmaceuticals has received USFDA approval for its Abbreviated New Drug Application (ANDA) for Sumatriptan single-dose autoinjector, deemed therapeutically equivalent to GlaxoSmithKline’s Imitrex STATdose System in 4 mg/0.5 mL and 6 mg/0.5 mL strengths.
Ascelia Pharma Strengthens Market Protection for Orviglance with New Patent Filing
Sweden-based biotech company Ascelia Pharma has filed a new patent application for its first-in-class orphan liver imaging drug, Orviglance.
ABPI Calls for Urgent Steps to Boost UK Life Sciences Investment in Pre-Budget Submission
The Association of the British Pharmaceutical Industry (ABPI) has called on the government to take urgent action to reverse a decade-long decline in investment and restore the UK’s position as a global leader in life sciences.
Novo Nordisk Confirms No Further Proposal Increase for Metsera Acquisition
Novo Nordisk has confirmed that it will not increase its offer to acquire Metsera, ending speculation of a potential bidding escalation.
Eli Lilly and SanegeneBio Partner to Develop RNAi Therapies for Metabolic Diseases
SanegeneBio, a clinical-stage biotechnology company developing RNAi therapeutics, has entered into a global research and licensing collaboration with Eli Lilly and Company to advance RNAi candidates for metabolic diseases.
Phase 3 results show Dupixent significantly improved nasal symptoms and sinus health in patients aged six and above with allergic fungal rhinosinusitis, supporting its FDA priority review.
Dyadic International, Inc. (operating as Dyadic Applied BioSolutions), a US-based biotechnology innovator, has appointed international business development consultancy Intralink to expand its commercial presence in Japan and South Korea — two of Asia’s fastest-growing and most advanced biopharmaceutical markets.
Harbour BioMed and Evinova Partner to Advance AI-Driven Biologics Development
Harbour BioMed (HBM), a global biopharmaceutical company focused on innovative antibody therapeutics in immunology and oncology, has entered into a strategic collaboration with Evinova, a global health-tech company dedicated to advancing digital health solutions for the life sciences sector.
ClearPoint Neuro Acquires IRRAS to Boost Neuro Drug Delivery Portfolio
Its cornerstone product is the IRRAflow system, a US FDA-cleared and CE-marked platform which integrates continuous irrigation, aspiration, and real-time intracranial pressure monitoring.
FireGate Biotech Emerges as a New Force in Translational Immunology
Rather than chasing single indications, FireGate’s framework is designed as an adaptable immune network, a modular system capable of responding to multiple disease environments and evolving alongside the immune landscape itself.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy